CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands		Total	Series C Preferred Stock	Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury Stock, at cost
Beginning balance (in shares) at Dec. 31, 2024				95,784,903
Beginning balance at Dec. 31, 2024				$ 207,470
Ending balance (in shares) at Mar. 31, 2025				95,784,903
Ending balance at Mar. 31, 2025				$ 207,470
Beginning balance (in shares) at Dec. 31, 2024					4,890,575
Beginning balance at Dec. 31, 2024		$ (8,263)			$ 5	$ 1,714,052	$ (18,068)	$ (1,474,268)	$ (229,984)
Increase (Decrease) in Stockholders' Equity
Net loss		(3,993)						(3,993)
Series B convertible redeemable preferred stock dividends	[1]	(4,439)						(4,439)
Restricted stock units distributed (in shares)					22,511
Amortization of stock-based compensation		284				284
Settlement of restricted stock unit liability		314				314
Foreign currency translation adjustment		2,639					2,639
Ending balance (in shares) at Mar. 31, 2025					4,913,086
Ending balance at Mar. 31, 2025		(13,458)			$ 5	1,714,650	(15,429)	(1,482,700)	(229,984)
Beginning balance (in shares) at Dec. 31, 2025			12,670,863
Beginning balance at Dec. 31, 2025		89,722	$ 89,722
Increase (Decrease) in Temporary Equity [Roll Forward]
Adjustment to issuance costs for recapitalization transaction	[1]		$ (68)
Ending balance (in shares) at Mar. 31, 2026			12,670,863
Ending balance at Mar. 31, 2026		$ 89,654	$ 89,654
Beginning balance (in shares) at Dec. 31, 2025		14,876,139			14,876,139
Beginning balance at Dec. 31, 2025		$ 111,439			$ 15	1,781,265	(9,862)	(1,429,995)	(229,984)
Increase (Decrease) in Stockholders' Equity
Net loss		(6,248)						(6,248)
Adjustment to issuance costs for recapitalization transaction	[1]	(50)				(50)
Restricted stock units distributed (in shares)					147,375
Amortization of stock-based compensation		208				208
Settlement of restricted stock unit liability		1,586				1,586
Foreign currency translation adjustment		$ (1,941)					(1,941)
Ending balance (in shares) at Mar. 31, 2026		15,023,514			15,023,514
Ending balance at Mar. 31, 2026		$ 104,994			$ 15	$ 1,783,009	$ (11,803)	$ (1,436,243)	$ (229,984)

[1] Transactions for these line items were exclusively with related parties. Refer to Footnote 4, Convertible Redeemable Preferred Stock and Stockholders' Equity (Deficit) and Footnote 8, Related Party Transactions.